Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05585710

Pulsed Lavage in Implant-Based Breast Reconstruction

Pulsed Lavage in Implant-Based Breast Reconstruction: A Randomized Control Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
62 (estimated)
Sponsor
University of Alabama at Birmingham · Academic / Other
Sex
Female
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To determine if there is any benefit to using pulsed lavage to wash out the mastectomy pocket during breast reconstruction. Primary outcomes will include post-op complications including surgical site infection (SSI), hematoma, seroma, and implant failure.

Detailed description

After being informed of the study including potential risks and benefits, all patients giving consent who meet eligibility requirements will undergo randomization into either the pulsed lavage arm (receive mastectomy pocket wash out using pulsed lavage) or the no pulsed lavage arm (pulsed lavage will not be used). Randomization will occur using a random number generator with even numbers resulting in a pulsed lavage washout and odd numbers resulting in no pulsed lavage washout. The patients will be followed in clinic for a maximum of 3 months to evaluate the surgical site. The two cohorts will be compared at the end of the study to determine whether there is any benefit to using pulsed lavage to wash out the mastectomy pocket during breast reconstruction.

Conditions

Interventions

TypeNameDescription
OTHERPulsed Lavage WashoutUse of pressurized, pulsed triple antibiotic solution to irrigate mastectomy pocket
PROCEDUREImplant-based breast reconstructionStandard of care; use of triple antibiotic solution delivered via bulb syringes to irrigate mastectomy pocket
PROCEDUREBilateral or unilateral mastectomyStandard of care
DEVICETissue expanderStandard of care
OTHERAcellular dermal matrixStandard of care

Timeline

Start date
2024-03-01
Primary completion
2026-03-01
Completion
2026-08-01
First posted
2022-10-19
Last updated
2025-04-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05585710. Inclusion in this directory is not an endorsement.